Discovery of potent and bioavailable GSK-3β inhibitors
摘要:
Here we report on the discovery of a series of maleimides which have high potency and good selectivity for GSK-3 beta. The incorporation of polar groups afforded compounds with good bioavailability. The most potent compound 34 has an IC(50) of 0.6 nM for GSK-3 beta, over 100-fold selectivity against a panel of other kinases, and shows efficacy in rat osteoporosis models. The X-ray structure of GSK-3 beta protein with 34 bound revealed the binding mode of the template and provided insights for future optimization opportunities. (C) 2010 Elsevier Ltd. All rights reserved.
[EN] USE OF A GSK-3BETA INHIBITOR IN THE MANUFACTURE OF A MEDICAMENT FOR INCREASING BONE FORMATION<br/>[FR] UTILISATION D'UN INHIBITEUR DE GSK-3 BETA DANS LA FABRICATION D'UN MEDICAMENT POUR ACCROITRE LA FORMATION OSSEUSE
申请人:HOFFMANN LA ROCHE
公开号:WO2003057202A1
公开(公告)日:2003-07-17
This invention relates to the use of inhibitors of glycogen synthase kinase-3β to increase bone formation.
本发明涉及使用糖原合酶激酶-3β抑制剂来增加骨形成。
Advanced drug development and manufacturing
申请人:Los Alamos National Security, LLC
公开号:EP2511844A2
公开(公告)日:2012-10-17
There is described an apparatus for measuring protein characteristics comprising an X-ray fluorescence (XRF) spectrometer comprising a source of polychromatic X-rays, an X-ray detector, a protein, a molecule that has been exposed to and at least weakly binds to the protein, a plurality of X-ray fluorescence signal data obtained by irradiating chemical elements in the protein and molecule with the polychromatic X-rays and a security system for maintaining records for the data from the plurality of X-ray fluorescence signal measurements. There is also described an x-ray microscope for measuring a sample.
描述了一种测量蛋白质特性的仪器,该仪器包括一个 X 射线荧光 (XRF) 光谱仪,其中包括一个多色 X 射线源、一个 X 射线探测器、一个蛋白质、一个已暴露于该蛋白质并至少与该蛋白质弱结合的分子、通过用多色 X 射线照射蛋白质和分子中的化学元素而获得的多个 X 射线荧光信号数据,以及一个用于维护多个 X 射线荧光信号测量数据记录的安全系统。此外,还介绍了一种用于测量样品的 X 射线显微镜。
3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA
申请人:F. HOFFMANN-LA ROCHE AG
公开号:EP1307447A2
公开(公告)日:2003-05-07
USE OF A GSK-3BETA INHIBITOR IN THE MANUFACTURE OF A MEDICAMENT FOR INCREASING BONE FORMATION